银屑病关节炎的诊治现状与挑战

摘要/Abstract

中图分类号:

R593.2

戴生明. 银屑病关节炎的诊治现状与挑战[J]. 内科理论与实践, 2022, 17(03): 186-189.

参考文献29

[1]	FitzGerald O, Ogdie A, Chandran V, et al. Psoriatic arthritis[J]. Nat Rev Dis Primers, 2021, 7(1): 59. doi:10.1038/s41572-021-00293-ypmid:34385474
[2]	Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome[J]. Ann Rheum Dis, 2005, 64 Suppl 2:ii14-ii17. doi:10.1136/ard.2004.032482pmid:15708927
[3]	van der Heijde D, Gladman DD, Kavanaugh A, et al. Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research[J]. Arthritis Res Ther, 2020, 22(1): 18. doi:10.1186/s13075-020-2103-8 URL
[4]	McHugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study[J]. Rheumatology (Oxford), 2003, 42(6): 778-783. doi:10.1093/rheumatology/keg217 URL
[5]	Charlton R, Green A, Shaddick G, et al. Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study[J]. Rheumatology(Oxford), 2019, 58(1): 144-148. doi:10.1093/rheumatology/key286 URL
[6]	Favarato MH, Mease P, Gonçalves CR, et al. Hypertension and diabetes significantly enhance the risk of cardiovascular disease in patients with psoriatic arthritis[J]. Clin Exp Rheumatol, 2014, 32(2): 182-187. pmid:24480317
[7]	Szentpetery A, Healy GM, Brady D, et al. Higher coronary plaque burden in psoriatic arthritis is independent of metabolic syndrome and associated with underlying disease severity[J]. Arthritis Rheumatol, 70(3): 396-407. doi:10.1002/art.40389 URL
[8]	Rosen CF, Mussani F, Chandran V, et al. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone[J]. Rheumatology, 2012, 51(3):571-576. doi:10.1093/rheumatology/ker365 URL
[9]	Chen Z, Xu Y, Chen M, et al. Gout augments the risk of cardiovascular disease in patients with psoriasis[J]. Front Immunol, 2021, 12: 703119. doi:10.3389/fimmu.2021.703119 URL
[10]	丁晓岚, 王婷琳, 沈佚葳, 等. 中国六省市银屑病流行病学调查[J]. 中国皮肤性病学杂志, 2010, 24(7): 598-601.
[11]	Reich K, Krüger K, Mössner R, et al. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis[J]. Br J Dermatol, 2009, 160(5): 1040-1047. doi:10.1111/j.1365-2133.2008.09023.xpmid:19210498
[12]	Guillen Astete CA, Gaite Gonzalez I, Zurita Prada PA, et al. Delay and diagnostic pathway of patients with psoriatic arthritis in Spain[J]. Reumatol Clin (Engl Ed), 2020, 17(9): 525-529.
[13]	Karmacharya P, Wright K, Achenbach SJ, et al. Diagnostic delay in psoriatic arthritis[J]. J Rheumatol, 2021, 48(9): 1410-1416. doi:10.3899/jrheum.201199pmid:33589556
[14]	Cui R, Chen M, Li X, et al. Assessment of four screening tools and retrieval of key questions to detect undiagnosed psoriatic arthritis in Chinese patients with psoriasis[J]. J Dermatol, 2022, 49(6): 615-623. doi:10.1111/1346-8138.16355 URL
[15]	Tinazzi I, Adami S, Zanolin EM, et al. The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis[J]. Rheumatology, 2012, 51(11): 2058-2063. doi:10.1093/rheumatology/kes187pmid:22879464
[16]	Ibrahim GH, Buch MH, Lawson C, et al. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire[J]. Clin Exp Rheumatol, 2009, 27(3): 469-474. pmid:19604440
[17]	Lindqvist UR, Alenius GM, Husmark T, et al. The Swedish early psoriatic arthritis register- 2-year followup[J]. J Rheumatol, 2008, 35(4): 668-673. pmid:18278834
[18]	Kane D, Stafford L, Bresnihan B, et al. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience[J]. Rheumatology, 2003, 42(12): 1460-1468. doi:10.1093/rheumatology/keg384 URL
[19]	Kane D, Pathare S. Early psoriatic arthritis[J]. Rheum Dis Clin North Am, 2005, 31(4): 641-657. doi:10.1016/j.rdc.2005.07.009 URL
[20]	Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis[J]. Ann Rheum Dis, 2015, 74(6): 1045-1050. doi:10.1136/annrheumdis-2013-204858 URL
[21]	Weisman MH, Witter JP, Reveille JD. The prevalence of inflammatory back pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009-10[J]. Ann Rheum Di, 2013, 72(3): 369-373.
[22]	Dai SM, Han XH, Zhao DB, et al. Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China[J]. J Rheumatol, 2003, 30(10): 2245-2251.
[23]	Xiang YJ, Dai SM. Prevalence of rheumatic diseases and disability in China[J]. Rheumatol Int, 2009, 29(5): 481-490. doi:10.1007/s00296-008-0809-z URL
[24]	Kingsley GH, Kowalczyk A, Taylor H, et al. A randomized placebo-controlled trial of methotrexate in psoriatic arthritis[J]. Rheumatology (Oxford), 2012, 51(8):1368-1377. doi:10.1093/rheumatology/kes001 URL
[25]	Ramiro S, Smolen JS, Landewé R, et al. Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis[J]. Ann Rheum Dis, 2016, 75(3): 490-498. doi:10.1136/annrheumdis-2015-208466pmid:26660203
[26]	Acosta Felquer ML, Coates LC, Soriano ER, et al. Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review[J]. J Rheumatol, 2014, 41(11): 2277-2285. doi:10.3899/jrheum.140876pmid:25362711
[27]	Kaltwasser JP, Nash P, Gladman D, et al. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial[J]. Arthritis Rheum, 2004, 50(6): 1939-1950. doi:10.1002/art.20253 URL
[28]	Zardin-Moraes M, da Silva ALFA, Saldanha C, et al. Prevalence of psoriatic arthritis patients achieving minimal disease activity in real-world studies and randomized clinical trials[J]. J Rheumatol, 2020, 47(6): 839-846. doi:10.3899/jrheum.190677pmid:31575702
[29]	Chen M, Zhang H, Chen Z, et al. Perceptions of rheumatologists on diagnosis of psoriatic arthritis in China[J]. Front Immunol, 2021, 12:733708. doi:10.3389/fimmu.2021.733708 URL

银屑病关节炎的诊治现状与挑战

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献29

相关文章15

编辑推荐

Metrics

本文评价

[1]	车稳, 柳蒋书, 陈晓炎, 王朝夫, 袁菲, 王璇.肺混合性鳞状细胞和腺性乳头状瘤2例临床病理特征及冷冻切片病理诊断误诊分析[J]. 诊断学理论与实践, 2022, 21(04): 476-481.
[2]	史玉玲.英国《皮肤科医师协会银屑病生物制剂治疗指南》（2020版）解读[J]. 诊断学理论与实践, 2021, 20(01): 37-42.
[3]	黄丹, 陈崑.银屑病相关流行病学调查进展[J]. 诊断学理论与实践, 2021, 20(01): 48-52.
[4]	史冬梅, 王晓琳, 陈璐, 谢青.曼氏裂头蚴病52例临床特点及误诊分析[J]. 诊断学理论与实践, 2020, 19(1): 37-43.
[5]	王加临, 刘怡.颈总动脉旁副甲状腺超声误诊1例分析[J]. 诊断学理论与实践, 2019, 18(06): 683-684.
[6]	王宁, 王尧, 王晓, 朱莹莹, 周罗成, 康健, 王海嵘,.51例菊池病患者临床资料回顾性分析[J]. 内科理论与实践, 2019, 14(04): 214-218.
[7]	赵伟伟, 王柳清, 张守成.垂体催乳素瘤误诊为病毒性脑炎报告及文献复习[J]. 诊断学理论与实践, 2018, 17(06): 723-725.
[8]	戴生明.银屑病关节炎的危害、诊治现状[J]. 诊断学理论与实践, 2018, 17(03): 238-243.
[9]	王荟, 刘坤, 陈佳, 房振, 高扬, 吴丽莉.甲状腺髓样癌细针穿刺被误诊为甲状腺乳头状癌1例报道[J]. 诊断学理论与实践, 2018, 17(03): 337-340.
[10]	林镇, 郭茹茹, 吕良敬, 陈晓翔.Fra2通过调节白细胞介素23受体参与银屑病发病的研究[J]. 诊断学理论与实践, 2018, 17(03): 254-259.
[11]	张姗姗, 杨玲.肺栓塞误诊为肺炎的原因分析[J]. 诊断学理论与实践, 2017, 16(05): 549-552.
[12]	潘丽萍, 慈光胜, 宋宏, 邵振华,.58例急性肺栓塞误诊分析[J]. 内科理论与实践, 2016, 11(04): 250-251.
[13]	吴云林, 毛峻岭, 吴巍, 黄天生, 陆敏, 陈晓敏, 罗方秀, 陆亭伟, 袁晓琴, 李佑, 项明,.2013年上海嘉定地区胃镜筛查胃癌漏诊的临床研究[J]. 诊断学理论与实践, 2014, 13(04): 383-387.
[14]	郑叶, 童海涛, 曾东, 杨月香, 冯艳玲, 卢洪洲,.艾滋病合并眼、胰腺和脾结核误诊为肿瘤3例临床与病理分析[J]. 诊断学理论与实践, 2014, 13(02): 187-192.
[15]	郭海英, 包婺平, 周新,.隐源性机化性肺炎误诊社区获得性肺炎24例并文献复习[J]. 诊断学理论与实践, 2013, 12(02): 166-169.